Dirt Cheap Stocks to Buy With $1,000 Right Now

The article highlights three consumer stocks as undervalued ideas: e.l.f. Beauty at 15x forward 2026 earnings, Chewy at under 14x, and JAKKS Pacific at 10x 2026 earnings and under 7x 2027 estimates. e.l.f. has a growth runway from Rhode and Sephora expansion, Chewy is targeting 10% adjusted EBITDA margins from 5.7% last year, and JAKKS has catalysts from an anime/manga platform launching next year. The piece is broadly bullish on fundamentals and future catalysts, but it is opinionated commentary rather than a company-specific news event.

Analysis

The common thread is not “cheap consumer” so much as operating leverage hidden inside depressed sentiment. ELF and CHWY are the cleaner quality/value hybrids: both can re-rate if execution stays intact because the market is still underwriting them like low-growth retailers, while the underlying model is shifting toward higher-margin mix and better monetization per customer. In both cases, the second-order winner is not just the company itself but adjacent suppliers and service partners that benefit as distribution broadens and order density improves; the biggest loser is the bear case built on cyclical demand collapse, which looks less relevant than incremental share capture and margin normalization.

CHWY is the more visible near-term catalyst because margin expansion is a compounding story rather than a one-time product cycle. The market will likely reward each quarterly beat with multiple expansion if management keeps proving that automation and mix shift are converting into durable EBITDA dollars; if margins stall for even one quarter, however, the stock can derate quickly because the current thesis is so dependent on operating leverage. The key risk is that advertising, pharmacy, and vet care investments cannibalize near-term profitability before they scale, creating a timing mismatch between capex/opex and realized gross profit.

JAKK is the more asymmetric, but also the least “clean” to underwrite. The market is pricing it as a trough earnings story, yet the real optionality is a multi-year IP/merchandise platform that could expand beyond traditional toy seasonality if the anime/manga initiative lands; that would be a meaningfully different margin profile, not just a sales bump. The contrarian angle is that consensus may be underestimating how much of the upside is already embedded in low expectations, but also overestimating how quickly licensing and tooling investments can translate into earnings without execution slippage and working-capital pressure.

Key Decisions for Investors

• Long ELF on a 6-12 month horizon; highest-quality risk/reward if Rhode distribution continues scaling through Sephora and beyond. Add on pullbacks rather than chasing, with downside protected by the core mass-beauty franchise.
• Long CHWY into the next 2-3 earnings prints; use a call spread if you want to express margin-expansion upside with defined risk. The trade works if EBITDA margin expansion stays on track and management keeps proving operating leverage.
• Pair long CHWY / short a lower-quality discretionary retailer over 3-6 months to isolate margin durability versus pure demand beta. This is a cleaner expression than a naked long if consumer data stays noisy.
• Speculative long JAKK only as a small position sized for optionality, not core capital, with a 12-24 month time horizon. Best entry is on weakness before catalyst visibility improves; the risk is delayed monetization and working-capital drag.
• Avoid shorting any of the three outright unless fundamentals deteriorate sharply; the setup is more about multiple re-rating from low expectations than explosive top-line growth, which makes shorts vulnerable to any incremental beat.